What happens if the EGFR gene is mutated?
EGFR (epidermal growth factor receptor) is a protein on cells that helps them grow. A mutation in the gene for EGFR can make it grow too much, which can cause cancer. There are different types of EGFR mutations.
What is the most common EGFR mutation?
The two most common EGFR mutations are short in-frame deletions of exon 19 and a point mutation (CTG to CGG) in exon 21 at nucleotide 2573, which results in substitution of leucine by arginine at codon 858 (L858R).
What is exon mutation?
EGFR exon 20 insertion mutations are heterogeneous at the molecular level but can be characterized as inframe insertions or duplications of between 3 and 21 bp (corresponding to 1 to 7 amino acids) clustered between amino acid positions 762 and 774 of the EGFR protein.
What is EGFR mutation status?
Objective. Epidermal growth factor receptor (EGFR) gene mutation status is a well-established predictor of the efficacy of EGFR tyrosine-kinase inhibitor (TKI) therapy in patients with non–small cell lung cancer.
What causes EGFR to mutate?
An EGFR mutation occurs when there is an error in the DNA that makes up the protein. These errors are also a type of biomarker. A biomarker is a biological molecule that can be an indicator of a certain condition or disease, according to the National Cancer Institute .
What is exon 20 insertion mutation?
Background: Epidermal growth factor receptor gene (EGFR) exon 20 insertion (ex20-ins) mutations are an uncommon and heterogeneous group of non-small cell lung cancers (NSCLCs), resistant to conventional EGFR tyrosine kinase inhibitors (TKIs).
How common is EGFR mutation?
Activating mutations in the epidermal growth factor receptor (EGFR) gene occur in 10–20% of Caucasian and at least 50% of Asian non-small cell lung cancer (NSCLC) patients [[1], [2], [3], [4]].
What is the prevalence of EGFR exon 19 mutations in humans?
Eight cases (0.26%) tested positive for EGFRexon 19 insertions (Supplementary Figure), thus comprising approximately 2% of exon 19 mutations and approximately 1% of all EGFRmutations.
Are egfrexon 19 insertions a new family of sensitizing EGFR mutations in lung adenocarcinoma?
In conclusion, we have shown that EGFRexon 19 insertions are a new family of sensitizing EGFRmutations in lung adenocarcinoma, and recommend that patients with tumors harboring these mutations be considered for upfront therapy with TKIs like erlotinib or gefitinib.
How many amino acids are deleted from the EGFR exon 19?
The most frequently observed EGFR exon 19 deletion leads to elimination of 5 amino acids (E746-A750) between the third β-strand of the EGFR tyrosine kinase domain and its key regulatory αC helix ( 9 ). However, a number of other exon 19 deletion mutations have also been observed in NSCLC between amino acids 745 and 753 ( 10 ).
Does EGFR deletion mutation affect kinase activity in non-small cell lung cancer?
Here, we examined a common EGFR deletion mutation, Δ746ELREA750, which is frequently observed in non-small cell lung cancer patients. By using molecular dynamics simulation, we investigated the structural effects of the mutation that lead to the experimentally reported increases in kinase activity.